GB201208409D0 - Vesicular formulations, kits and uses - Google Patents

Vesicular formulations, kits and uses

Info

Publication number
GB201208409D0
GB201208409D0 GBGB1208409.1A GB201208409A GB201208409D0 GB 201208409 D0 GB201208409 D0 GB 201208409D0 GB 201208409 A GB201208409 A GB 201208409A GB 201208409 D0 GB201208409 D0 GB 201208409D0
Authority
GB
United Kingdom
Prior art keywords
kits
vesicular formulations
vesicular
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1208409.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sequessome Technology Holdings Ltd
Original Assignee
Sequessome Technology Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sequessome Technology Holdings Ltd filed Critical Sequessome Technology Holdings Ltd
Priority to GBGB1208409.1A priority Critical patent/GB201208409D0/en
Publication of GB201208409D0 publication Critical patent/GB201208409D0/en
Priority to PCT/EP2013/059741 priority patent/WO2013171132A1/en
Priority to EP13723075.1A priority patent/EP2849722A1/en
Priority to DE112013002488.8T priority patent/DE112013002488T8/de
Priority to CN201380037307.2A priority patent/CN104619311A/zh
Priority to US14/400,874 priority patent/US20150132349A1/en
Priority to IN10135DEN2014 priority patent/IN2014DN10135A/en
Priority to HK15109428.6A priority patent/HK1209026A1/xx
Priority to JP2015512005A priority patent/JP2015516454A/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
GBGB1208409.1A 2012-05-14 2012-05-14 Vesicular formulations, kits and uses Ceased GB201208409D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB1208409.1A GB201208409D0 (en) 2012-05-14 2012-05-14 Vesicular formulations, kits and uses
PCT/EP2013/059741 WO2013171132A1 (en) 2012-05-14 2013-05-10 Vesicular formulations, kits and uses
EP13723075.1A EP2849722A1 (en) 2012-05-14 2013-05-10 Vesicular formulations, kits and uses
DE112013002488.8T DE112013002488T8 (de) 2012-05-14 2013-05-10 Vesikuläre Formulierungen, Kits und Verwendungen
CN201380037307.2A CN104619311A (zh) 2012-05-14 2013-05-10 囊泡制剂、试剂盒和用途
US14/400,874 US20150132349A1 (en) 2012-05-14 2013-05-10 Vesicular Formulations, Kits and Uses
IN10135DEN2014 IN2014DN10135A (en:Method) 2012-05-14 2013-05-10
HK15109428.6A HK1209026A1 (en) 2012-05-14 2013-05-10 Vesicular formulations, kits and uses
JP2015512005A JP2015516454A (ja) 2012-05-14 2013-05-10 ベシクル製剤のキットおよび使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1208409.1A GB201208409D0 (en) 2012-05-14 2012-05-14 Vesicular formulations, kits and uses

Publications (1)

Publication Number Publication Date
GB201208409D0 true GB201208409D0 (en) 2012-06-27

Family

ID=46458763

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1208409.1A Ceased GB201208409D0 (en) 2012-05-14 2012-05-14 Vesicular formulations, kits and uses

Country Status (9)

Country Link
US (1) US20150132349A1 (en:Method)
EP (1) EP2849722A1 (en:Method)
JP (1) JP2015516454A (en:Method)
CN (1) CN104619311A (en:Method)
DE (1) DE112013002488T8 (en:Method)
GB (1) GB201208409D0 (en:Method)
HK (1) HK1209026A1 (en:Method)
IN (1) IN2014DN10135A (en:Method)
WO (1) WO2013171132A1 (en:Method)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102770162B (zh) 2009-08-21 2016-09-28 靶向递送技术有限公司 囊泡制剂
GB201205642D0 (en) 2012-03-29 2012-05-16 Sequessome Technology Holdings Ltd Vesicular formulations
EP3954361A1 (en) * 2015-06-30 2022-02-16 Sequessome Technology Holdings Limited Multiphasic compositions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2661673B1 (fr) * 1990-05-07 1992-08-21 Oreal Association de dihydroxyacetone et de monohydroxyindoles pour conferer a la peau une coloration similaire au bronzage naturel, dispositif a plusieurs compartiments et procede de mise en óoeuvre.
US6165500A (en) 1990-08-24 2000-12-26 Idea Ag Preparation for the application of agents in mini-droplets
JP3765579B2 (ja) 1990-08-24 2006-04-12 イーデーエーアー アーゲー 作用物質投与用超微小滴状調剤
SK284338B6 (sk) * 1997-11-19 2005-02-04 Schering Aktiengesellschaft Kompozícia s kyselinou azelaínovou
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6191121B1 (en) * 2000-04-06 2001-02-20 Nicholas V. Perricone Treatment of skin damage using polyenylphosphatidylcholine
FR2823100B1 (fr) * 2001-04-10 2003-05-30 Oreal Procede de maquillage bicouche et kit de maquillage contenant des premiere et seconde compositions
US20040105881A1 (en) 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
CN100506847C (zh) * 2003-02-25 2009-07-01 雅臣药业集团（远东）有限公司 用于防治口腔疾病的IgY制备方法以及基于该IgY的牙膏
EP1938801A1 (en) * 2006-12-22 2008-07-02 Biofrontera Bioscience GmbH Nanoemulsion
DE112010001765T5 (de) 2009-06-03 2012-12-27 George Langton Iliffe Formulierungen zur Behandlung von Gewebetiefenschmerz
CN102770162B (zh) * 2009-08-21 2016-09-28 靶向递送技术有限公司 囊泡制剂
US20110273379A1 (en) * 2010-05-05 2011-11-10 Google Inc. Directional pad on touchscreen

Also Published As

Publication number Publication date
CN104619311A (zh) 2015-05-13
DE112013002488T8 (de) 2015-02-19
IN2014DN10135A (en:Method) 2015-08-21
HK1209026A1 (en) 2016-03-24
DE112013002488T5 (de) 2015-01-29
EP2849722A1 (en) 2015-03-25
JP2015516454A (ja) 2015-06-11
US20150132349A1 (en) 2015-05-14
WO2013171132A1 (en) 2013-11-21

Similar Documents

Publication Publication Date Title
IL254143A0 (en) Methylphenidate-medications, processes for their preparation and use
GB2499921B (en) Biophotonic compositions, kits and methods
IL234014A0 (en) Cycloalkane derivatives, preparations containing them and their uses
IL237068A (en) 1,3-dioxanomorphides and 1,3-dioxanocodides
IL237926A0 (en) Combinations and their uses
ZA201501124B (en) Trans-clomiphene formulations and uses thereof
IL233824A (en) Compounds 1h - Indazole - 3 - Carboxamide, preparations containing them and their use
ZA201405392B (en) Substituted phenylimidazopyrazoles and use thereof
EP2837627A4 (en) AMIDOPYRIDINE DERIVATIVE AND USE THEREOF
IL237542A0 (en) Amphiphilic compounds, their preparations and uses
ZA201504127B (en) Split axle, axle-hub unit and use thereof
IL234747A0 (en) Vascular formulations
IL236568A0 (en) Uses of alkylthiophene-rich compositions and methods of creating these compositions
IL233682A0 (en) Modified phenylazole derivatives, preparations containing them and their uses
IL267888B (en) Amphiphilic compounds, their preparations and uses
GB201208409D0 (en) Vesicular formulations, kits and uses
IL237540B (en) Amphiphilic compounds, their preparations and uses
GB201208384D0 (en) Vesicular formulations, uses and methods
IL237539A0 (en) Amphiphilic compounds, their preparations and uses
IL237538B (en) Amphiphilic compounds, their preparations and uses
PL2722572T3 (pl) Układ przewodu rurowego, zwłaszcza do zastosowania w zakresie techniki powietrznej
EP2944172A4 (en) AXIS IN TWO PARTS, AXLE-HUB ASSEMBLY AND USE THEREOF
GB201208360D0 (en) Vesicular formulations,kits and uses

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)